We are live on ! Find out more
EMR

Errol M. Rudman Portfolio holdings

AUM $148M
1-Year Est. Return 19.65%
This Fund
S&P 500
This Quarter Est. Return
+17.45%
1 Year Est. Return
+19.65%
3 Year Est. Return
+60.53%
5 Year Est. Return
+120.34%
10 Year Est. Return
–
AUM
$148M
AUM Growth
+$4.82M
Cap. Flow
-$12.2M
Cap. Flow %
-8.25%
Top 10 Hldgs %
77.35%
Holding
30
New
1
Increased
4
Reduced
5
Closed
2

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$824K
2
IMMU
Immunomedics Inc
IMMU
+$564K
3
BFYT
Benefytt Technologies, Inc. Class A Common Stock
BFYT
+$159K
4
WAB icon
Wabtec
WAB
+$144K
5
CVS icon
CVS Health
CVS
+$123K

Top Sells

Rank Stock Value
1
TDG icon
TransDigm Group
TDG
+$4.06M
2
HCA icon
HCA Healthcare
HCA
+$2.28M
3
UAL icon
United Airlines
UAL
+$1.94M
4
CNC icon
Centene
CNC
+$1.82M
5
WFC icon
Wells Fargo
WFC
+$1.38M

Sector Composition

Rank Sector Weight
1 Industrials 43.67%
2 Healthcare 25.81%
3 Technology 8.9%
4 Consumer Discretionary 7.4%
5 Financials 6.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TDG icon
1
TransDigm Group
TDG
$67.9B
$36.2M 24.44%
79,736
-10,000
-11% -$4.06M
UAL icon
2
United Airlines
UAL
$37.5B
$16.1M 10.87%
201,783
-23,000
-10% -$1.94M
CNC icon
3
Centene
CNC
$32.8B
$13.5M 9.12%
254,400
-30,000
-11% -$1.82M
MDB icon
4
MongoDB
MDB
$25.1B
$12.6M 8.54%
86,000
– –
DAL icon
5
Delta Air Lines
DAL
$55.4B
$9.21M 6.22%
178,410
-24,000
-12% -$1.19M
HCA icon
6
HCA Healthcare
HCA
$82.3B
$8.21M 5.54%
62,970
-17,000
-21% -$2.28M
CBPO
7
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$5.29M 3.57%
58,000
– –
JPM icon
8
JPMorgan Chase
JPM
$907B
$4.77M 3.22%
47,110
+8,000
+20% +$824K
MHK icon
9
Mohawk Industries
MHK
$6.8B
$4.31M 2.91%
34,200
– –
RUSHA icon
10
Rush Enterprises Class A
RUSHA
$5.98B
$4.3M 2.9%
231,278
– –
LUMN icon
11
Lumen
LUMN
$6.47B
$4.13M 2.79%
344,841
– –
CVS icon
12
CVS Health
CVS
$137B
$3.92M 2.65%
72,704
+2,000
+3% +$123K
ADUS icon
13
Addus HomeCare
ADUS
$2.14B
$3.66M 2.47%
57,548
– –
BFYT
14
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
$2.81M 1.89%
104,608
+4,500
+4% +$159K
CI icon
15
Cigna
CI
$74.5B
$2.64M 1.78%
16,423
– –
FND icon
16
Floor & Decor
FND
$6.14B
$2.35M 1.58%
56,895
– –
GS icon
17
Goldman Sachs
GS
$314B
$1.99M 1.34%
10,340
– –
XRAY icon
18
Dentsply Sirona
XRAY
$2.81B
$1.98M 1.34%
40,000
– –
TMO icon
19
Thermo Fisher Scientific
TMO
$198B
$1.67M 1.13%
6,090
– –
WAB icon
20
Wabtec
WAB
$44.5B
$1.44M 0.97%
19,500
+2,000
+11% +$144K
MOH icon
21
Molina Healthcare
MOH
$11.7B
$1.39M 0.94%
9,800
– –
YI
22
111 Inc
YI
$31.9M
$1.24M 0.84%
19,171
– –
ROK icon
23
Rockwell Automation
ROK
$51.4B
$877K 0.59%
5,000
– –
VLRS
24
Controladora Vuela Compania de Aviacion
VLRS
$880M
$850K 0.57%
99,784
– –
GLIBA
25
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
$834K 0.56%
15,000
– –
1
2

Similar funds

HAM
Hillswick Asset Management Stamford, Connecticut $150M AUM 7.89% 1-Year Est. Return
TAM
Taylor Asset Management Toronto, Ontario, Canada $154M AUM 10.32% 1-Year Est. Return
RMPT
Raytheon Master Pension Trust Waltham, Massachusetts $140M AUM 5.65% 1-Year Est. Return
QAM
Quantres Asset Management Cayman, Cayman Islands $138M AUM 11.79% 1-Year Est. Return
CWM
Catamount Wealth Management Westport, Connecticut $176M AUM 15.01% 1-Year Est. Return
RCA
Restructuring Capital Associates Stamford, Connecticut $115M AUM 20.18% 1-Year Est. Return
CI
Caerus Investors New York $183M AUM 0.18% 1-Year Est. Return
LS
Lattice Strategies Wayne, Pennsylvania $109M AUM 3.52% 1-Year Est. Return

Errol M. Rudman's Q1 2019 Portfolio in Review

As of Q1 2019, Errol M. Rudman held 30 positions worth $148M, up 3.4% from $143M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Errol M. Rudman withdrew a net $12.2M in Q1 2019, closing 2 positions and reducing 5 holdings. Its most notable exit was Wells Fargo, an estimated $1.38M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 44% of assets, up from 43% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Errol M. Rudman opened a new position in Immunomedics Inc worth $672K.

  • Errol M. Rudman's largest Q1 2019 buy was Immunomedics Inc: 35,000 shares worth $672K.
  • Errol M. Rudman added most to JPMorgan Chase in Q1 2019, an estimated $824K increase.
  • Errol M. Rudman's biggest Q1 2019 reduction was TransDigm Group, cutting an estimated $4.06M.
  • Errol M. Rudman fully exited Wells Fargo in Q1 2019, selling an estimated $1.38M.
  • Errol M. Rudman's ten largest holdings make up 77% of its $148M portfolio in Q1 2019.
  • Errol M. Rudman opened 1 new position and closed 2 in Q1 2019.
  • Errol M. Rudman's portfolio value rose 3.4% quarter-over-quarter to $148M.

Based on Errol M. Rudman's 13F filing for Q1 2019, filed 15 May 2019.